tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,083 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 1.13, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 74.54, while Halozyme Therapeutics’s (HALO) share price is $74.94, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 70.40, while Halozyme Therapeutics’s (HALO) share price is $74.94, making it a Buy.

Halozyme (HALO) Pivot Points

Oct 02, 2025, 10:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
70.75
71.90
72.62
73.78
74.50
75.65
76.37
Fibonacci
71.90
72.62
73.06
73.78
74.49
74.93
75.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Oct 02, 2025, 10:33 AM
Period
Simple
Exponential
MA5
73.86Buy
74.40Buy
MA10
75.53Sell
74.88Buy
MA20
75.69Sell
74.54Buy
MA50
69.68Buy
70.40Buy
MA100
62.16Buy
65.71Buy
MA200
59.80Buy
61.34Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 74.88, while Halozyme Therapeutics’s (HALO) share price is $74.94, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 65.71, while Halozyme Therapeutics’s (HALO) share price is $74.94, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $74.94 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 69.68, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $74.94 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 62.16, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $74.94 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 59.80, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Oct 02, 2025, 10:33 AM
Name
Value
Implied Action
RSI (14)
55.95
Neutral
STOCH (9,6)
11.78
Buy
STOCHRSI (14)
11.78
Buy
MACD (12,26)
1.13
Buy
ADX (14)
42.03
Neutral
Williams %R
-70.75
Buy
CCI (14)
-30.58
Neutral
ATR (14)
1.86
-
Ultimate Oscillator
31.44
Neutral
ROC
-3.34
Sell
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 55.95, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 42.03, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -30.58, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is -3.34, creating a Sell signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Strong Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 55.95, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is 1.13, which suggests HALO is a Buy.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 73.86, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 75.69, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 69.68, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 59.80, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -70.75, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -30.58, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis